Together we will beat cancer

Donate
Jacob Smith

Jacob is a Digital News Officer at Cancer Research UK. He studied biochemistry at the University of Exeter and subsequently completed a Master’s in science communication at Imperial College London. He joined the digital news team in March 2022, writing for the news site and contributing to our podcast, That Cancer Conversation.

New analysis reveals Black women in England more likely to be diagnosed with late-stage cancer

A new study has revealed that Black women from Caribbean and African backgrounds are more likely to be diagnosed with certain types of cancer at later stages, when treatment is less likely to be successful. 

Read More

England slips further off-track for smokefree 2030 target

The UK government is almost a decade behind achieving its target for England to be smokefree by 2030, a new report reveals.

Read More

The future of research: meet three of our scientists working on TRACERx

We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today. 

Read More

First-of-its-kind app for patients on clinical trials being piloted by Cancer Research UK

Cancer Research UK, in partnership with tech company Stitch, are going live with an app for patients to use whilst participating in a clinical trial.  

Read More

Why do non-smokers face delays in getting a lung cancer diagnosis?

Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer

Read More

Repurposing radiotherapy drugs could give immunotherapy a boost

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

Read More

Why consistent and funded cancer policies are key to improving cancer survival

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

Read More

Stopping the spread: A revolution in how we think about metastasis

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

Read More

How “the most advanced machine learning approach” is finding new cancer-causing mutational signatures

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that’s quickly establishing itself as the best of the best.  

Read More

NICE doesn’t recommend olaparib for patients with certain prostate cancers

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

Read More